This bibliography shows the most interesting papers selected from pmc PubMedCentral which were newly included in covid010D It is available online and for download at http://www.kidney.de/write/PMCmedVIP_covid010D.html Skewed: Nephrology, Rheumatology, Immunology, Cell Biology, Research Methods. on-topic and educational Clinical Medicine. The full table of all monthly collections is: at house-of-papers.com PMC searches were done at moremed.org
PMC7311595 1. Diabetes increases the mortality of patients with COVID-19: a meta-analysis.
8. ADL-dependency, D-Dimers, LDH and absence of anticoagulation are independently associated with one-month mortality in older inpatients with Covid-19.
PMC7322811 27. Update Alert: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.
PMC7302923 38. Application of System Biology to Explore the Association of Neprilysin, Angiotensin-Converting Enzyme 2 (ACE2), and Carbonic Anhydrase (CA) in Pathogenesis of SARS-CoV-2.
{{tp|p=32583078|t=2020. Diabetes increases the mortality of patients with COVID-19: a meta-analysis.|pdf=|usr=}} {{tp|p=32562214|t=2020. Neurological manifestations of COVID-19, SARS and MERS.|pdf=|usr=}} {{tp|p=32557901|t=2020. Lactoferrin is an important factor when breastfeeding and COVID-19 are considered.|pdf=|usr=}} {{tp|p=32557789|t=2020. Novel Coronavirus Infection (COVID-19) in Children Younger Than One Year: A Systematic Review of Symptoms, Management and Outcomes.|pdf=|usr=}} {{tp|p=32544288|t=2020. Appropriate care for neonates born to mothers with COVID-19 disease.|pdf=|usr=}} {{tp|p=32565054|t=2020. Chilblain y lesiones purpuricas acrales en COVID-19.|pdf=|usr=}} {{tp|p=32566237|t=2020. Protracted course of coronavirus disease with severe acute respiratory distress syndrome: a case report.|pdf=|usr=}} {{tp|p=32576712|t=2020. ADL-dependency, D-Dimers, LDH and absence of anticoagulation are independently associated with one-month mortality in older inpatients with Covid-19.|pdf=|usr=}} {{tp|p=32575078|t=2020. Risk factors for 2019 novel coronavirus disease (COVID-19) patients progressing to critical illness: a systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32575073|t=2020. Clinical characteristics of older and younger patients infected with SARS-CoV-2.|pdf=|usr=}} {{tp|p=32568102|t=2020. Lessons from a lumbar burst fracture patient infected with SARS-CoV-2.|pdf=|usr=}} {{tp|p=32561692|t=2020. Prognosis analysis of patients with mental disorders with COVID-19: a single-center retrospective study.|pdf=|usr=}} {{tp|p=32557332|t=2020. COVID-19 and the elderly: insights into pathogenesis and clinical decision-making.|pdf=|usr=}} {{tp|p=32566368|t=2020. COVID-19 and HELLP: Overlapping Clinical Pictures in Two Gravid Patients.|pdf=|usr=}} {{tp|p=32400878|t=2020. Alcohol and COVID-19.|pdf=|usr=}} {{tp|p=32544254|t=2020. COVID-19 in a patient with severe asthma treated with Omalizumab.|pdf=|usr=}} {{tp|p=32578167|t=2020. COVID-19 Pandemic: Cardiovascular Complications and Future Implications.|pdf=|usr=}} {{tp|p=32553914|t=2020. Exposure and Seroconversion to SARS-CoV-2 Among Obstetric Healthcare Providers Following a Contained Outbreak.|pdf=|usr=}} {{tp|p=32553910|t=2020. Maternal Mortality Among Women with COVID-19 Admitted to the Intensive Care Unit.|pdf=|usr=}} {{tp|p=32553908|t=2020. COVID-19 in pregnancy was associated with maternal morbidity and preterm birth.|pdf=|usr=}} {{tp|p=32574896|t=2020. Symptomatology in head and neck district in coronavirus disease (COVID-19): A possible neuroinvasive action of SARS-CoV-2.|pdf=|usr=}} {{tp|p=32574110|t=2020. Maternal and Neonatal Response to COVID-19.|pdf=|usr=}} {{tp|p=32565254|t=2020. Activation of the Renin-angiotensin-aldosterone system is associated with Acute Kidney injury in COVID-19.|pdf=|usr=}} {{tp|p=32588614|t=2020. A 56-year-old man with RT-PCR negative nasopharyngeal swabs with Coronavirus Disease 2019 (COVID-19) Pneumonia.|pdf=|usr=}} {{tp|p=32591877|t=2020. SARS-CoV-2-associated cold agglutinin disease: a report of two cases.|pdf=|usr=}} {{tp|p=32542444|t=2020. COVID-19 infection associated with autoimmune hemolytic anemia.|pdf=|usr=}} {{tp|p=32584593|t=2020. Update Alert: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.|pdf=|usr=}} {{tp|p=32562741|t=2020. On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2.|pdf=|usr=}} {{tp|p=32561401|t=2020. COVID-19 in patients with lung cancer.|pdf=|usr=}} {{tp|p=32576016|t=2020. Investigation of COVID-19-related symptoms based on factor analysis.|pdf=|usr=}} {{tp|p=32546598|t=2020. Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study.|pdf=|usr=}} {{tp|p=32589931|t=2020. A case of Covid-19 patient with acute limb ischemia and heparin resistance.|pdf=|usr=}} {{tp|p=32572616|t=2020. Laboratory characteristics of pregnant compared to non-pregnant women infected with SARS-CoV-2.|pdf=|usr=}} {{tp|p=32563232|t=2020. Olfactory and gustatory dysfunctions in COVID-19 patients: A systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32563234|t=2020. Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options.|pdf=|usr=}} {{tp|p=32586739|t=2020. ENT manifestation in COVID-19 patients.|pdf=|usr=}} {{tp|p=32579957|t=2020. SARS-CoV-2 and Cardiovascular Complications: from Molecular Mechanisms to Pharmaceutical Management.|pdf=|usr=}} {{tp|p=32572334|t=2020. Application of System Biology to Explore the Association of Neprilysin, Angiotensin-Converting Enzyme 2 (ACE2), and Carbonic Anhydrase (CA) in Pathogenesis of SARS-CoV-2.|pdf=|usr=}} {{tp|p=32574369|t=2020. COVID-19 coagulopathy vs disseminated intravascular coagulation.|pdf=|usr=}} {{tp|p=32559290|t=2020. A report of clustered COVID-19 in a hematology ward.|pdf=|usr=}} {{tp|p=32576139|t=2020. Risk factors for disease progression in COVID-19 patients.|pdf=|usr=}} {{tp|p=32571228|t=2020. Clinical and CT findings of COVID-19: differences among three age groups.|pdf=|usr=}} {{tp|p=32571224|t=2020. COVID-19 with acute cholecystitis: a case report.|pdf=|usr=}} {{tp|p=32552751|t=2020. Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran.|pdf=|usr=}} {{tp|p=32586323|t=2020. COVID-19: a retrospective cohort study with focus on the over-80s and hospital-onset disease.|pdf=|usr=}} {{tp|p=32552792|t=2020. Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19.|pdf=|usr=}} {{tp|p=32546557|t=2020. COVID-19 presenting as severe, persistent abdominal pain and causing late respiratory compromise in a 33-year-old man.|pdf=|usr=}} {{tp|p=32541689|t=2020. COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma.|pdf=|usr=}} {{tp|p=32590055|t=2020. A brewing storm: The neuropsychological sequelae of hyperinflammation due to COVID-19.|pdf=|usr=}} {{tp|p=32561222|t=2020. Spectrum of neuropsychiatric manifestations in COVID-19.|pdf=|usr=}} {{tp|p=32589258|t=2020. Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients.|pdf=|usr=}} {{tp|p=32592657|t=2020. In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19.|pdf=|usr=}} {{tp|p=32564306|t=2020. Fatal SARS-CoV-2 infection in a renal transplant recipient.|pdf=|usr=}} {{tp|p=32557209|t=2020. The first case of COVID-19 pneumonia in a hemodialysis patient in Japan.|pdf=|usr=}} {{tp|p=32589950|t=2020. COVID-19 Pneumonia Hospitalizations Followed by Re-presentation for Presumed Thrombotic Event.|pdf=|usr=}} {{tp|p=32583150|t=2020. Neurological manifestations of pediatric multi-system inflammatory syndrome potentially associated with COVID-19.|pdf=|usr=}} {{tp|p=32554734|t=2020. Gastrointestinal manifestations of COVID-19.|pdf=|usr=}} {{tp|p=32562427|t=2020. Cardiovascular manifestations in severe and critical patients with COVID-19.|pdf=|usr=}} {{tp|p=32553907|t=2020. Characteristics of liver function in patients with SARS-CoV-2 and chronic HBV co-infection.|pdf=|usr=}} {{tp|p=32569835|t=2020. Characteristics of 1,573 healthcare workers who underwent nasopharyngeal swab for SARS-CoV-2 in Milano, Lombardy, Italy.|pdf=|usr=}} {{tp|p=32565320|t=2020. High rate of pulmonary thromboembolism in patients with SARS-CoV-2 pneumonia.|pdf=|usr=}} {{tp|p=32577830|t=2020. Is the oral cavity relevant in SARS-CoV-2 pandemic?|pdf=|usr=}} {{tp|p=32562070|t=2020. A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab.|pdf=|usr=}} {{tp|p=32578830|t=2020. Gynecology and women's health care during the COVID-19 pandemic: Patient safety in surgery and prevention.|pdf=|usr=}} {{tp|p=32586839|t=2020. Death, discharge and arrhythmias among patients with COVID-19 and cardiac injury.|pdf=|usr=}} {{tp|p=32586835|t=2020. COVID-19 and myocardial injury.|pdf=|usr=}} {{tp|p=32560665|t=2020. "War to the knife" against thromboinflammation to protect endothelial function of COVID-19 patients.|pdf=|usr=}} {{tp|p=32560658|t=2020. Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring.|pdf=|usr=}} {{tp|p=32552872|t=2020. Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis.|pdf=|usr=}}
70. Taste and Smell Impairment in SARS-CoV-2 Recovers Early and Spontaneously: Experimental Data Strongly Linked to Clinical Data.
95. Clinical course and outcome of COVID-19 in patients with rheumatic diseases: are all biological disease-modifying antirheumatic drugs alike? Response to: 'Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab' by Schulze-Koops et al.
99. Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments.
100. Response to: 'Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors' by Jovani et al.
102. Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China 'hot spot' versus in US 'hot spot': similarities and differences.
{{tp|p=32539346|t=2020. Taste and Smell Impairment in SARS-CoV-2 Recovers Early and Spontaneously: Experimental Data Strongly Linked to Clinical Data.|pdf=|usr=}} {{tp|p=32571007|t=2020. Nanotechnology for COVID-19: Therapeutics and Vaccine Research.|pdf=|usr=}} {{tp|p=32544373|t=2020. Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case report and review of the literature.|pdf=|usr=}} {{tp|p=32588911|t=2020. Promoting attachment between parents and neonates despite the COVID-19 pandemic.|pdf=|usr=}} {{tp|p=32586968|t=2020. COVID-19 Is an Independent Risk Factor for Acute Ischemic Stroke.|pdf=|usr=}} {{tp|p=32586960|t=2020. Anosmia in COVID-19 Associated with Injury to the Olfactory Bulbs Evident on MRI.|pdf=|usr=}} {{tp|p=32586959|t=2020. Leukoencephalopathy Associated with Severe COVID-19 Infection: Sequela of Hypoxemia?|pdf=|usr=}} {{tp|p=32586958|t=2020. COVID-19-Associated Bifacial Weakness with Paresthesia Subtype of Guillain-Barre Syndrome.|pdf=|usr=}} {{tp|p=32554426|t=2020. CT Fluid-Blood Levels in COVID-19 Intracranial Hemorrhage.|pdf=|usr=}} {{tp|p=32554425|t=2020. COVID-19 Neurologic Complication with CNS Vasculitis-Like Pattern.|pdf=|usr=}} {{tp|p=32554424|t=2020. Cerebral Venous Thrombosis Associated with COVID-19.|pdf=|usr=}} {{tp|p=32554423|t=2020. Atypical Deep Cerebral Vein Thrombosis with Hemorrhagic Venous Infarction in a Patient Positive for COVID-19.|pdf=|usr=}} {{tp|p=32559115|t=2020. Evidence of Added Value of Chest CT in Coronavirus Disease (COVID-19) Pneumonia With Initial Negative RT-PCR Results.|pdf=|usr=}} {{tp|p=32553913|t=2020. Estimating frequency of severe disease in pregnant patients with COVID-19.|pdf=|usr=}} {{tp|p=32553911|t=2020. Diagnosis of COVID-19 pneumonia in pregnant women: can we rely on lung ultrasound?|pdf=|usr=}} {{tp|p=32588404|t=2020. You Don't Have To Be Infected To Suffer: COVID-19 and Racial Disparities in Severe Maternal Morbidity and Mortality.|pdf=|usr=}} {{tp|p=32575140|t=2020. Putting It All Together: Clinical Considerations in the Care of Critically Ill Obstetric Patients with COVID-19.|pdf=|usr=}} {{tp|p=32544961|t=2020. Preventing COVID-19 Transmission on Labor and Delivery: A Decision Analysis.|pdf=|usr=}} {{tp|p=32576749|t=2020. Letter to the Editor on "Rehabilitation following critical illness in people with COVID-19 infection".|pdf=|usr=}} {{tp|p=32588801|t=2020. Primary Symptoms, Comorbidities, and Outcomes of 431 Hospitalized Patients with Confirmative RT-PCR Results for COVID-19.|pdf=|usr=}} {{tp|p=32563271|t=2020. Case Report: A COVID-19 Patient Presenting with Mild Rhabdomyolysis.|pdf=|usr=}} {{tp|p=32562808|t=2020. Left ventricular dysfunction in COVID-19: A diagnostic issue.|pdf=|usr=}} {{tp|p=32578263|t=2020. Could SARS-CoV-2 affect male fertility?|pdf=|usr=}} {{tp|p=32589451|t=2020. Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study.|pdf=|usr=}} {{tp|p=32538098|t=2020. Extensive pneumatosis intestinalis and portal venous gas mimicking mesenteric ischaemia in a patient with SARS-CoV-2.|pdf=|usr=}} {{tp|p=32591359|t=2020. Clinical course and outcome of COVID-19 in patients with rheumatic diseases: are all biological disease-modifying antirheumatic drugs alike? Response to: 'Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab' by Schulze-Koops et al.|pdf=|usr=}} {{tp|p=32591357|t=2020. Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab.|pdf=|usr=}} {{tp|p=32591356|t=2020. Case of acute arthritis following SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32586922|t=2020. Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors.|pdf=|usr=}} {{tp|p=32586921|t=2020. Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments.|pdf=|usr=}} {{tp|p=32586919|t=2020. Response to: 'Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors' by Jovani et al.|pdf=|usr=}} {{tp|p=32546603|t=2020. COVID-19 in patients with rheumatological diseases treated with anti-TNF.|pdf=|usr=}} {{tp|p=32546602|t=2020. Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China 'hot spot' versus in US 'hot spot': similarities and differences.|pdf=|usr=}} {{tp|p=32586828|t=2020. Incidence of SARS-CoV-2 vertical transmission: a meta-analysis.|pdf=|usr=}} {{tp|p=32551814|t=2020. Coagulation dysfunction: A hallmark in COVID-19.|pdf=|usr=}} {{tp|p=32583553|t=2020. Do pregnant women have protective immunity against COVID-19?|pdf=|usr=}} {{tp|p=32570284|t=2020. Can COVID-19 in pregnancy cause preeclampsia?|pdf=|usr=}} {{tp|p=32559762|t=2020. Red cell bound antibodies and transfusion requirements in hospitalized patients with COVID-19.|pdf=|usr=}} {{tp|p=32556139|t=2020. Morphological changes in a case of SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32556137|t=2020. Hemophagocytic lymphohistiocytosis in SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32540857|t=2020. Distinguishing between direct and indirect consequences of covid-19.|pdf=|usr=}} {{tp|p=32587121|t=2020. Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19.|pdf=|usr=}} {{tp|p=32587120|t=2020. 'Ring of fire' appearance in COVID-19 pneumonia.|pdf=|usr=}}
PMC7301352 113. The unique characteristics of COVID-19 coagulopathy.
PMC7296517 114. Liver injury without liver failure in COVID-19 patients: how to explain, in some cases, elevated ammonia without hepatic decompensation.
PMC7296879 121. Humidifier Use and Prone Positioning in a Patient with Severe COVID-19 Pneumonia and Endotracheal Tube Impaction Due to Highly Viscous Sputum.
PMC7323037 125. Patients with specific skin disorders who are affected by COVID-19: what do experiences say about management strategies? : A systematic review.
PMC7323023 126. Comment on "Are erythema multiforme and urticaria related to a better outcome of COVID 19?". Eosinophils count in 7 patients with COVID-19 and urticarial rash.
PMC7323020 129. Comment on "Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine": report of a COVID-19 patient with particular findings.
PMC7314685 131. Clinical Characteristics and Outcome in Patients with Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State Associated with COVID-19: A Retrospective, Hospital-Based Observational Case Series.
138. Mutter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2-spezifischer Antikorper bei 401 Rostocker Muttern mittels ELISA und Immunfluoreszenz-Bestatigungstest.
150. Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies.
PMC7314072 151. A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
PMC7323336 155. Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy.
159. Epidemic and pandemic viral infections: impact on tuberculosis and the lung. A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN) and members(#) of ESCMID Study Group for Mycobacterial Infections (ESGMYC).
179. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
PMC7301795 183. Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: mini-review of the literature.
PMC7307495 187. Clinical epidemiological analyses of overweight/obesity and abnormal liver function contributing to prolonged hospitalization in patients infected with COVID-19.
{{tp|p=32552865|t=2020. The unique characteristics of COVID-19 coagulopathy.|pdf=|usr=}} {{tp|p=32546201|t=2020. Liver injury without liver failure in COVID-19 patients: how to explain, in some cases, elevated ammonia without hepatic decompensation.|pdf=|usr=}} {{tp|p=32546191|t=2020. Incidence of acute kidney injury in COVID-19 infection: a systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32546188|t=2020. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32539863|t=2020. Clinical features and outcomes of COVID-19 patients with gastrointestinal symptoms.|pdf=|usr=}} {{tp|p=32539827|t=2020. Early rehabilitation with dedicated use of belt-type electrical muscle stimulation for severe COVID-19 patients.|pdf=|usr=}} {{tp|p=32577331|t=2020. Atypical Manifestation of COVID-19-Induced Myocarditis.|pdf=|usr=}} {{tp|p=32550096|t=2020. COVID-19 Induced Hepatitis B Virus Reactivation: A Novel Case From the United Arab Emirates.|pdf=|usr=}} {{tp|p=32550095|t=2020. Humidifier Use and Prone Positioning in a Patient with Severe COVID-19 Pneumonia and Endotracheal Tube Impaction Due to Highly Viscous Sputum.|pdf=|usr=}} {{tp|p=32556892|t=2020. The Role of Anticoagulation in COVID-19-Induced Hypercoagulability.|pdf=|usr=}} {{tp|p=32591908|t=2020. Relationship Between ACE2 and Other Components of the Renin-Angiotensin System.|pdf=|usr=}} {{tp|p=32558172|t=2020. SARS-COV-2 As Possible Inducer of Viral Reactivations.|pdf=|usr=}} {{tp|p=32558193|t=2020. Patients with specific skin disorders who are affected by COVID-19: what do experiences say about management strategies? : A systematic review.|pdf=|usr=}} {{tp|p=32544263|t=2020. Comment on "Are erythema multiforme and urticaria related to a better outcome of COVID 19?". Eosinophils count in 7 patients with COVID-19 and urticarial rash.|pdf=|usr=}} {{tp|p=32544259|t=2020. Is herpes zoster being an indicator for COVID 19 infection?|pdf=|usr=}} {{tp|p=32543757|t=2020. Dermatological findings in SARS-CoV-2 positive patients: An observational study from North India.|pdf=|usr=}} {{tp|p=32543708|t=2020. Comment on "Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine": report of a COVID-19 patient with particular findings.|pdf=|usr=}} {{tp|p=32542925|t=2020. Lichenoid eruptions with interface dermatitis and necrotic subepidermal blister associated with COVID-19.|pdf=|usr=}} {{tp|p=32592843|t=2020. Clinical Characteristics and Outcome in Patients with Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State Associated with COVID-19: A Retrospective, Hospital-Based Observational Case Series.|pdf=|usr=}} {{tp|p=32592839|t=2020. Retinal outcomes of COVID-19: possible role of CD147 and cytokine storm in infected patients with diabetes mellitus.|pdf=|usr=}} {{tp|p=32592836|t=2020. Well-controlled vs Poorly-controlled Diabetes in Patients with COVID-19: Are There Any Differences in Outcomes and Imaging Findings?|pdf=|usr=}} {{tp|p=32558652|t=2020. COVID-19 pneumonia in a Turkish child presenting with abdominal complaints and reversed halo sign on thorax CT.|pdf=|usr=}} {{tp|p=32537704|t=2020. PPIs and Beyond: A Framework for Managing Anticoagulation-Related Gastrointestinal Bleeding in the Era of COVID-19.|pdf=|usr=}} {{tp|p=32592868|t=2020. Direct SARS-CoV-2 infection of the heart potentiates the cardiovascular sequelae of COVID-19.|pdf=|usr=}} {{tp|p=32562843|t=2020. COVID-19 and pneumonia: a role for the uPA/uPAR system.|pdf=|usr=}} {{tp|p=32572869|t=2020. Mutter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2-spezifischer Antikorper bei 401 Rostocker Muttern mittels ELISA und Immunfluoreszenz-Bestatigungstest.|pdf=|usr=}} {{tp|p=32579877|t=2020. Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients.|pdf=|usr=}} {{tp|p=32568662|t=2020. Clinical Course of Asymptomatic and Mildly Symptomatic Patients with Coronavirus Disease Admitted to Community Treatment Centers, South Korea.|pdf=|usr=}} {{tp|p=32574107|t=2020. Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?|pdf=|usr=}} {{tp|p=32552365|t=2020. Antibodies in the breast milk of a maternal woman with COVID-19.|pdf=|usr=}} {{tp|p=32578011|t=2020. Consideration on TMPRSS2 and the risk of COVID-19 infection in Cushing's syndrome.|pdf=|usr=}} {{tp|p=32580531|t=2020. Follow up investigation of asymptomatic COVID-19 cases at diagnosis in Busan, Korea.|pdf=|usr=}} {{tp|p=32583183|t=2020. Ethyl alcohol threshold test: a fast, reliable and affordable olfactory Assessment tool for COVID-19 patients.|pdf=|usr=}} {{tp|p=32577904|t=2020. Gustatory dysfunctions in COVID-19.|pdf=|usr=}} {{tp|p=32577902|t=2020. Olfactory and gustatory abnormalities in COVID-19 cases.|pdf=|usr=}} {{tp|p=32577901|t=2020. Isolated olfactory cleft involvement in SARS-CoV-2 infection: prevalence and clinical correlates.|pdf=|usr=}} {{tp|p=32556781|t=2020. Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence.|pdf=|usr=}} {{tp|p=32567326|t=2020. Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies.|pdf=|usr=}} {{tp|p=32542337|t=2020. A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.|pdf=|usr=}} {{tp|p=32558922|t=2020. Personalized recovery of severe COVID19: Rehabilitation from the perspective of patient needs.|pdf=|usr=}} {{tp|p=32557325|t=2020. Effect of angiotensin II blockers on the prognosis of COVID-19: a toxicological view.|pdf=|usr=}} {{tp|p=32557918|t=2020. Janus faced course of COVID-19 infection in patients with hematological malignancies.|pdf=|usr=}} {{tp|p=32544294|t=2020. Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy.|pdf=|usr=}} {{tp|p=32558002|t=2020. The international EAN survey on neurological symptoms in patients with COVID-19 infection.|pdf=|usr=}} {{tp|p=32539312|t=2020. Systematic rapid living review on rehabilitation needs due to Covid-19: update to May 31st 2020.|pdf=|usr=}} {{tp|p=32586888|t=2020. On Tuberculosis and COVID-19 co-infection.|pdf=|usr=}} {{tp|p=32586885|t=2020. Epidemic and pandemic viral infections: impact on tuberculosis and the lung. A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN) and members(#) of ESCMID Study Group for Mycobacterial Infections (ESGMYC).|pdf=|usr=}} {{tp|p=32586883|t=2020. Impaired pulmonary function in discharged patients with COVID-19: More work ahead.|pdf=|usr=}} {{tp|p=32554537|t=2020. The (in)significance of TB and COVID-19 co-infection.|pdf=|usr=}} {{tp|p=32554533|t=2020. Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post infection.|pdf=|usr=}} {{tp|p=32554532|t=2020. Thrombosis and COVID-19 pneumonia: the clot thickens!|pdf=|usr=}} {{tp|p=32586841|t=2020. COVID-19 and pulmonary rehabilitation: preparing for phase three.|pdf=|usr=}} {{tp|p=32591101|t=2020. Re: Androgen-deprivation Therapies for Prostate Cancer and Risk of Infection by SARS-CoV-2: A Population-based Study (n=4532).|pdf=|usr=}} {{tp|p=32569772|t=2020. Poor outcome of intestinal ischemic manifestations of COVID 19.|pdf=|usr=}} {{tp|p=32571973|t=2020. Risk factors in patients with COVID-19 developing severe liver injury during hospitalisation.|pdf=|usr=}} {{tp|p=32585191|t=2020. COVID-19 and Cardiac Arrhythmias.|pdf=|usr=}} {{tp|p=32572363|t=2020. Unique case of central retinal artery occlusion secondary to COVID-19 disease.|pdf=|usr=}} {{tp|p=32572692|t=2020. Impact of COVID-19 Pneumonia on Neonatal Birth Outcomes.|pdf=|usr=}} {{tp|p=32572691|t=2020. The Challenges of Contact Tracing in a Case of Early Neonatal Sepsis with COVID-19.|pdf=|usr=}} {{tp|p=32548735|t=2020. Fatal Covid-19 in a Malnourished Child with Megaloblastic Anemia.|pdf=|usr=}} {{tp|p=32583809|t=2020. COVID-19-associated Hemophagocytic Lymphohistiocytosis and Coagulopathy: Targeting the Duumvirate.|pdf=|usr=}} {{tp|p=32562397|t=2020. Coronavirus Disease (COVID-19) and the Gastrointestinal System in Children.|pdf=|usr=}} {{tp|p=32564770|t=2020. Asymptomatic and Pre-Symptomatic COVID-19 in China.|pdf=|usr=}} {{tp|p=32560671|t=2020. A COVID-19 case report from asymptomatic contact: implication for contact isolation and incubation management.|pdf=|usr=}} {{tp|p=32557347|t=2020. Secondary tension pneumothorax in a COVID-19 pneumonia patient: a case report.|pdf=|usr=}} {{tp|p=32575825|t=2020. Deaths in SARS-Cov-2 Positive Patients in Italy: The Influence of Underlying Health Conditions on Lethality.|pdf=|usr=}} {{tp|p=32575505|t=2020. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.|pdf=|usr=}} {{tp|p=32560180|t=2020. Clinical Factors, Preventive Behaviours and Temporal Outcomes Associated with COVID-19 Infection in Health Professionals at a Spanish Hospital.|pdf=|usr=}} {{tp|p=32585286|t=2020. Occurrence of Acute Pulmonary Embolism in COVID-19 - A Case Series.|pdf=|usr=}} {{tp|p=32574691|t=2020. COVID-19 Concomitant Infective Endocarditis: A-Case Report and Review of Management.|pdf=|usr=}} {{tp|p=32565366|t=2020. Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: mini-review of the literature.|pdf=|usr=}} {{tp|p=32565365|t=2020. Ageusia, gastrointestinal symptoms and marked asthenia in late December. A single case report with positive SARS-Cov2 IgG in Italy.|pdf=|usr=}} {{tp|p=32562846|t=2020. Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32543260|t=2020. Ischemic stroke associated with novel coronavirus 2019: a report of three cases.|pdf=|usr=}} {{tp|p=32572128|t=2020. Clinical epidemiological analyses of overweight/obesity and abnormal liver function contributing to prolonged hospitalization in patients infected with COVID-19.|pdf=|usr=}} {{tp|p=32572532|t=2020. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.|pdf=|usr=}} {{tp|p=32572526|t=2020. Between-centre differences for COVID-19 ICU mortality from early data in England.|pdf=|usr=}} {{tp|p=32592761|t=2020. Acute abducens nerve palsy in a patient with the novel coronavirus disease (COVID-19).|pdf=|usr=}} {{tp|p=32561389|t=2020. Risk and Management of Patients with Mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) Pandemic: Expert Opinions.|pdf=|usr=}}
192. Loss of Taste and Smell as Distinguishing Symptoms of COVID-19.
{{tp|p=32562541|t=2020. Loss of Taste and Smell as Distinguishing Symptoms of COVID-19.|pdf=|usr=}} {{tp|p=32561913|t=2020. COVID-19 and the RAAS.|pdf=|usr=}} {{tp|p=32556328|t=2020. National French survey of COVID-19 symptoms in people aged 70 and over.|pdf=|usr=}} {{tp|p=32556141|t=2020. Persistent negative antibody test in COVID-19 patient: a case report.|pdf=|usr=}} {{tp|p=32548613|t=2020. Prevalence of COVID-19 Infection and Outcomes Among Symptomatic Healthcare Workers in Seattle, Washington.|pdf=|usr=}} {{tp|p=32544951|t=2020. SARS-CoV-2 antibodies in adults in Madrid, Spain.|pdf=|usr=}} {{tp|p=32544219|t=2020. Bacterial Pneumonia in COVID-19 critically ill patients: a case series.|pdf=|usr=}} {{tp|p=32571783|t=2020. The potential impacts of obesity on COVID-19.|pdf=|usr=}} {{tp|p=32589760|t=2020. Attenuated early inflammatory response in solid organ recipients with COVID-19.|pdf=|usr=}} {{tp|p=32568741|t=2020. Prognostic significance of cardiac injury in COVID-19 patients with and without coronary artery disease.|pdf=|usr=}} {{tp|p=32539446|t=2020. Obesity as a risk factor for COVID-19: an overview.|pdf=|usr=}} {{tp|p=32589314|t=2020. A case of erythema multiforme major in a patient with COVID 19: The role of corticosteroid treatment.|pdf=|usr=}} {{tp|p=32584451|t=2020. COVID-19 infection on IL-23 inhibition.|pdf=|usr=}} {{tp|p=32579756|t=2020. Cutaneous manifestations in hospitalized patients diagnosed as COVID-19.|pdf=|usr=}} {{tp|p=32585723|t=2020. Diagnosis of gestational diabetes during the pandemic: what is the risk of falling through the net?|pdf=|usr=}} {{tp|p=32588943|t=2020. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (COVID-19).|pdf=|usr=}} {{tp|p=32573903|t=2020. Prevalence of comorbidities and their association with mortality in patients with COVID-19: A Systematic Review and Meta-analysis.|pdf=|usr=}} {{tp|p=32576328|t=2020. Prediction of the rehabilitation duration and risk management for mild-moderate COVID-19.|pdf=|usr=}} {{tp|p=32580792|t=2020. Analysis of factors affecting the prognosis of COVID-19 patients and viral shedding duration.|pdf=|usr=}} {{tp|p=32589794|t=2020. Orbitofrontal involvement in a neuroCOVID-19 patient.|pdf=|usr=}} {{tp|p=32585699|t=2020. Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes.|pdf=|usr=}} {{tp|p=32577762|t=2020. Men more vulnerable to COVID-19: explained by ACE2 on the X chromosome?|pdf=|usr=}} {{tp|p=32577716|t=2020. ACE2 is on the X chromosome: could this explain COVID-19 gender differences?|pdf=|usr=}} {{tp|p=32562486|t=2020. COVID-19 kills at home: the close relationship between the epidemic and the increase of out-of-hospital cardiac arrests.|pdf=|usr=}} {{tp|p=32556106|t=2020. CMR and serology to diagnose COVID-19 infection with primary cardiac involvement.|pdf=|usr=}} {{tp|p=32568805|t=2020. Case series and review of liver dysfunction in COVID-19 patients.|pdf=|usr=}} {{tp|p=32558697|t=2020. COVID-19 and the liver: overview.|pdf=|usr=}} {{tp|p=32558696|t=2020. Covid-19 infection, liver injury and prognosis: a suggestion.|pdf=|usr=}} {{tp|p=32541245|t=2020. Immune monitoring of a child with autoimmune hepatitis and type 1 diabetes during COVID-19 infection.|pdf=|usr=}} {{tp|p=32593209|t=2020. Favorable COVID-19 course despite significant comorbidities in a ruxolitinib-treated patient with primary myelofibrosis.|pdf=|usr=}} {{tp|p=32589774|t=2020. Sickle Cell Trait and The Potential Risk of Severe Coronavirus Disease 2019- A Mini-Review.|pdf=|usr=}} {{tp|p=32575156|t=2020. COVID-19 complicated by parainfluenza co-infection in a patient with chronic lymphocytic leukemia.|pdf=|usr=}} {{tp|p=32573838|t=2020. COVID-19 and thalassaemia: A position statement of the Thalassaemia International Federation.|pdf=|usr=}}
PMC7323002 225. Minor aphthae associated with SARS-CoV-2 infection.
PMC7323041 229. Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy.
231. Presenting prevalence, characteristics and outcome of asthmatic patients with T2 diseases in hospitalized subjects with COVID-19 in Madrid, Spain.
PMC7297137 249. The "Three Italy" of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia.
PMC7313488 257. Coronavirus Disease (COVID-19) hospitalized patients with acute kidney injury (AKI) treated with acute peritoneal dialysis do not have infectious PD effluent.
273. Cardiac rehabilitation activities during the COVID-19 pandemic in Italy. Position Paper of the AICPR (Italian Association of Clinical Cardiology, Prevention and Rehabilitation).
{{tp|p=32557570|t=2020. Minor aphthae associated with SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32557532|t=2020. Complicated coronavirus disease 2019 (COVID-19) in a psoriatic patient treated with ixekizumab.|pdf=|usr=}} {{tp|p=32564417|t=2020. Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19.|pdf=|usr=}} {{tp|p=32558979|t=2020. An unusual case of bullous hemorrhagic vasculitis in a COVID-19 patient.|pdf=|usr=}} {{tp|p=32557889|t=2020. Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy.|pdf=|usr=}} {{tp|p=32557847|t=2020. Cutaneous involvement during COVID-19 pandemic: an emerging sign of infection.|pdf=|usr=}} {{tp|p=32554336|t=2020. Presenting prevalence, characteristics and outcome of asthmatic patients with T2 diseases in hospitalized subjects with COVID-19 in Madrid, Spain.|pdf=|usr=}} {{tp|p=32554337|t=2020. Smell and taste dysfunctions in COVID-19 are associated with younger age in ambulatory settings - a multicenter cross-sectional study.|pdf=|usr=}} {{tp|p=32537957|t=2020. Risk Factors for Mortality and Respiratory Support in Elderly Patients Hospitalized with COVID-19 in Korea.|pdf=|usr=}} {{tp|p=32537954|t=2020. Prognostic Factors for Severe Coronavirus Disease 2019 in Daegu, Korea.|pdf=|usr=}} {{tp|p=32576232|t=2020. A 95-year-old patient with unexpected coronavirus disease 2019 masked by aspiration pneumonia: a case report.|pdf=|usr=}} {{tp|p=32544071|t=2020. Identification of Symptoms Prognostic of COVID-19 Severity: Multivariate Data Analysis of a Case Series in Henan Province.|pdf=|usr=}} {{tp|p=32576457|t=2020. Anosmia and olfactory tract neuropathy in a case of COVID-19.|pdf=|usr=}} {{tp|p=32590125|t=2020. Guillain-Barre syndrome in a patient infected with SARS-CoV-2, a case report.|pdf=|usr=}} {{tp|p=32588185|t=2020. Acute inflammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS-CoV-2.|pdf=|usr=}} {{tp|p=32588182|t=2020. COVID-19 in dimethyl fumarate-treated patients with multiple sclerosis.|pdf=|usr=}} {{tp|p=32583054|t=2020. Characteristics and clinical course of Covid-19 patients admitted with acute stroke.|pdf=|usr=}} {{tp|p=32583053|t=2020. Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient.|pdf=|usr=}} {{tp|p=32577868|t=2020. Guillain-Barre syndrome in the COVID-19 era: another occasional cluster?|pdf=|usr=}} {{tp|p=32564153|t=2020. First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease.|pdf=|usr=}} {{tp|p=32561990|t=2020. Neurological involvement of coronavirus disease 2019: a systematic review.|pdf=|usr=}} {{tp|p=32556572|t=2020. Cerebral involvement in COVID-19 is associated with metabolic and coagulation derangements: an EEG study.|pdf=|usr=}} {{tp|p=32590204|t=2020. The association of SARS-CoV-2 infection and acute disseminated encephalomyelitis without prominent clinical pulmonary symptoms.|pdf=|usr=}} {{tp|p=32572835|t=2020. Intracranial hemorrhage complicating anticoagulant prophylactic therapy in three hospitalized COVID-19 patients.|pdf=|usr=}} {{tp|p=32548750|t=2020. The "Three Italy" of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia.|pdf=|usr=}} {{tp|p=32565097|t=2020. A Comparison Between Chinese Children Infected with COVID-19 and with SARS.|pdf=|usr=}} {{tp|p=32565095|t=2020. SARS-CoV-2 Infection in Infants Less than 90 Days Old.|pdf=|usr=}} {{tp|p=32561269|t=2020. Acute limb ischemia in COVID-19 patients: Could Aortic Floating Thrombus be the source of embolic complications?|pdf=|usr=}} {{tp|p=32561465|t=2020. Coagulopathy, thromboembolic complications and the use of heparin in COVID-19 Pneumonia.|pdf=|usr=}} {{tp|p=32561464|t=2020. Use of low-molecular-weight heparin in COVID-19 patients.|pdf=|usr=}} {{tp|p=32584397|t=2020. Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 Pandemic.|pdf=|usr=}} {{tp|p=32550733|t=2020. Pulmonary embolism and COVID-19. Persistent pulmonary hypertension?|pdf=|usr=}} {{tp|p=32592816|t=2020. Coronavirus Disease (COVID-19) hospitalized patients with acute kidney injury (AKI) treated with acute peritoneal dialysis do not have infectious PD effluent.|pdf=|usr=}} {{tp|p=32549526|t=2020. Persistent severe acute respiratory syndrome coronavirus 2 detection after resolution of coronavirus disease 2019-associated symptoms/signs.|pdf=|usr=}} {{tp|p=32563282|t=2020. Prognosis of patients with sickle cell disease and COVID-19: a French experience.|pdf=|usr=}} {{tp|p=32569623|t=2020. Association of mediastinal lymphadenopathy with COVID-19 prognosis.|pdf=|usr=}} {{tp|p=32563281|t=2020. Negative SARS-CoV-2 PCR in patients with chilblain-like lesions.|pdf=|usr=}} {{tp|p=32553187|t=2020. Seroconversion in household members of COVID-19 outpatients.|pdf=|usr=}} {{tp|p=32542755|t=2020. In Reference to Anosmia and Ageusia: Common Findings in COVID-19 Patients.|pdf=|usr=}} {{tp|p=32542703|t=2020. In Response to Isolated Anosmia and Ageusia in COVID-19 With Spontaneous Recovery.|pdf=|usr=}} {{tp|p=32546725|t=2020. Risk factors for death in 1859 subjects with COVID-19.|pdf=|usr=}} {{tp|p=32592918|t=2020. Is periodontal disease a risk factor for severe COVID-19 illness?|pdf=|usr=}} {{tp|p=32580461|t=2020. Report of Positive Placental Swabs for SARS-CoV-2 in an Asymptomatic Pregnant Woman with COVID-19.|pdf=|usr=}} {{tp|p=32590779|t=2020. Successful blood glucose management of a severe COVID-19 patient with diabetes: A case report.|pdf=|usr=}} {{tp|p=32589899|t=2020. Unexpected high mortality in COVID-19 and diabetic ketoacidosis.|pdf=|usr=}} {{tp|p=32561409|t=2020. Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster.|pdf=|usr=}} {{tp|p=32585364|t=2020. Diabetes, Infection Risk And Covid-19.|pdf=|usr=}} {{tp|p=32573175|t=2020. Italian suggestions for pulmonary rehabilitation in COVID-19 patients recovering from acute respiratory failure: results of a Delphi process.|pdf=|usr=}} {{tp|p=32548994|t=2020. Cardiac rehabilitation activities during the COVID-19 pandemic in Italy. Position Paper of the AICPR (Italian Association of Clinical Cardiology, Prevention and Rehabilitation).|pdf=|usr=}} {{tp|p=32593144|t=2020. Attenuation of antibody response to SARS-CoV-2 in a patient on ocrelizumab with hypogammaglobulinemia.|pdf=|usr=}} {{tp|p=32585617|t=2020. COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies.|pdf=|usr=}} {{tp|p=32564476|t=2020. SARS-CoV-2 and Oral Ulcers; a Causative Agent or a Predisposing Factor?|pdf=|usr=}} {{tp|p=32564416|t=2020. Altered Taste in Patients with COVID-19: The Potential Role of Salivary Glands.|pdf=|usr=}} {{tp|p=32558983|t=2020. Oral mucosa lesions in COVID-19.|pdf=|usr=}} {{tp|p=32543745|t=2020. Low prevalence of arrhythmias in clinically stable COVID-19 patients.|pdf=|usr=}}
280. COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead.
291. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) infection in cancer population: Are patient-related symptoms helpful to track a harmful invisible?
323. Impact of smoking status on disease severity and mortality of hospitalized patients with COVID-19 infection: a systematic review and meta-analysis.
328. Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers.
{{tp|p=32551971|t=2020. COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead.|pdf=|usr=}} {{tp|p=32553766|t=2020. Impact of Pre-existing Chronic Liver Disease on the Outcome of Patients with COVID-19 Disease.|pdf=|usr=}} {{tp|p=32571972|t=2020. COVID-19 in an international European liver transplant recipient cohort.|pdf=|usr=}} {{tp|p=32552139|t=2020. COVID-19 in a Patient with beta-Thalassemia Major and Severe Pulmonary Arterial Hypertension.|pdf=|usr=}} {{tp|p=32564694|t=2020. Sex-Specific Modulation of Blood Pressure and the Renin-Angiotensin System by ACE (Angiotensin-Converting Enzyme) 2.|pdf=|usr=}} {{tp|p=32564693|t=2020. Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension.|pdf=|usr=}} {{tp|p=32578527|t=2020. Prolonged Shedding of SARS-CoV-2 RNA among Patients with COVID-19.|pdf=|usr=}} {{tp|p=32579420|t=2020. Post discharge positive re-tests in COVID-19: common but clinically non-significant.|pdf=|usr=}} {{tp|p=32578860|t=2020. Prolonged Duration of SARS-CoV-2 Viral Positivity in a Crohn's Disease Patient.|pdf=|usr=}} {{tp|p=32578843|t=2020. From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area.|pdf=|usr=}} {{tp|p=32588537|t=2020. Challenges in interpreting the diagnostic performance of symptoms to predict COVID-19 status: the case of anosmia.|pdf=|usr=}} {{tp|p=32574373|t=2020. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) infection in cancer population: Are patient-related symptoms helpful to track a harmful invisible?|pdf=|usr=}} {{tp|p=32572958|t=2020. Chilblain-like lesions during the COVID-19 pandemic: early or late sign?|pdf=|usr=}} {{tp|p=32588051|t=2020. Epidemiological and clinical characteristics of 671 COVID-19 patients in Henan Province, China.|pdf=|usr=}} {{tp|p=32592539|t=2020. Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients: Retrospective analysis.|pdf=|usr=}} {{tp|p=32588061|t=2020. Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review).|pdf=|usr=}} {{tp|p=32568626|t=2020. Stroke in COVID-19 patients-A case series from Italy.|pdf=|usr=}} {{tp|p=32568768|t=2020. NO SIGNIFICANT EFFECT OF COVID-19 ON IMMUNOLOGICAL AND VIROLOGICAL PARAMETERS IN PATIENTS WITH HIV-1 INFECTION.|pdf=|usr=}} {{tp|p=32583434|t=2020. Neurological, Cognitive, and Behavioral Disorders during COVID-19: The Nitric Oxide Track.|pdf=|usr=}} {{tp|p=32556147|t=2020. Diabetic Ketoacidosis in COVID-19: unique concerns and considerations.|pdf=|usr=}} {{tp|p=32543328|t=2020. Herpes Zoster (shingles) complicating the course of COVID19 infection.|pdf=|usr=}} {{tp|p=32589301|t=2020. Acute acral cutaneous manifestations during the COVID-19 pandemic: a single center experience.|pdf=|usr=}} {{tp|p=32589294|t=2020. Recent outbreak of chilblain-like lesions is not directly related with SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32589293|t=2020. Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature.|pdf=|usr=}} {{tp|p=32588475|t=2020. Relapsing symmetric livedo reticularis in a patient with COVID-19 infection.|pdf=|usr=}} {{tp|p=32585074|t=2020. Cutaneous manifestations of SARS-CoV-2 infection: a clinical update.|pdf=|usr=}} {{tp|p=32589798|t=2020. Zero COVID-19 infection in inflammatory bowel disease patients: Findings from National IBD Registries in Hong Kong and Taiwan.|pdf=|usr=}} {{tp|p=32574567|t=2020. Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients.|pdf=|usr=}} {{tp|p=32585065|t=2020. Impact of Chronic Liver Disease on Outcomes of Hospitalized Patients with COVID-19: A Multicenter United States Experience.|pdf=|usr=}} {{tp|p=32573883|t=2020. Metabolic associated fatty liver disease is associated with severity of COVID-19.|pdf=|usr=}} {{tp|p=32572965|t=2020. COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS.|pdf=|usr=}} {{tp|p=32567656|t=2020. Sentinel Case of COVID-19 at Fort Stewart, GA in a National Guard Soldier Participating in Annual Training: A Case Report.|pdf=|usr=}} {{tp|p=32585069|t=2020. COVID-19 associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan.|pdf=|usr=}} {{tp|p=32579806|t=2020. Case 21-2020: A 66-Year-Old Homeless Man with Covid-19.|pdf=|usr=}} {{tp|p=32581323|t=2020. Determinants of COVID-19 disease severity in patients with cancer.|pdf=|usr=}} {{tp|p=32555424|t=2020. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.|pdf=|usr=}} {{tp|p=32541961|t=2020. Biobanks could identify medically actionable findings relevant for COVID-19 clinical care.|pdf=|usr=}} {{tp|p=32586898|t=2020. Pearls & Oy-sters: Bilateral globus pallidus lesions in a patient with COVID-19.|pdf=|usr=}} {{tp|p=32586897|t=2020. Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid.|pdf=|usr=}} {{tp|p=32554773|t=2020. Incidence and case fatality rate of COVID-19 in patients with active epilepsy.|pdf=|usr=}} {{tp|p=32554771|t=2020. New onset neurologic events in people with COVID-19 infection in three regions in China.|pdf=|usr=}} {{tp|p=32546655|t=2020. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19.|pdf=|usr=}} {{tp|p=32546654|t=2020. Early postmortem brain MRI findings in COVID-19 non-survivors.|pdf=|usr=}} {{tp|p=32564072|t=2020. Impact of smoking status on disease severity and mortality of hospitalized patients with COVID-19 infection: a systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32583537|t=2020. Should patients with obesity be more afraid of COVID-19?|pdf=|usr=}} {{tp|p=32567171|t=2020. The renin-angiotensin-aldosterone system as a link between obesity and coronavirus disease 2019 severity.|pdf=|usr=}} {{tp|p=32589784|t=2020. Obesity is Associated with Increased Risk for Mortality Among Hospitalized Patients with COVID-19.|pdf=|usr=}} {{tp|p=32590725|t=2020. Induction of Labor in an Intubated Patient With Coronavirus Disease 2019 (COVID-19).|pdf=|usr=}} {{tp|p=32555034|t=2020. Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers.|pdf=|usr=}} {{tp|p=32544146|t=2020. Severe Coronavirus Infections in Pregnancy: A Systematic Review.|pdf=|usr=}} {{tp|p=32544145|t=2020. Maternal Mortality From Coronavirus Disease 2019 (COVID-19) in the United States.|pdf=|usr=}} {{tp|p=32589459|t=2020. Ocular Surface Expression of SARS-CoV-2 Receptors.|pdf=|usr=}} {{tp|p=32569494|t=2020. Ocular Manifestations of Hospitalized Patients with COVID-19 in Northeast of Iran.|pdf=|usr=}} {{tp|p=32543262|t=2020. COVID-19 and the Ocular Surface: A Review of Transmission and Manifestations.|pdf=|usr=}} {{tp|p=32562704|t=2020. Ocular Signs of COVID-19 Suggested by Internet Search Term Patterns Worldwide.|pdf=|usr=}} {{tp|p=32592396|t=2020. Positive SARS-CoV-2 RNA recurs repeatedly in a case recovered from COVID-19: dynamic results from 108 days of follow-up.|pdf=|usr=}} {{tp|p=32576095|t=2020. Understanding the role that 'COVID toe' has in recognizing the potential extent of COVID-19 infections: a case study.|pdf=|usr=}}
PMC7306657 337. Myocardial injury in patients with COVID-19.
PMC7316360 365. Sociodemographic, clinical and laboratory factors on admission associated with COVID-19 mortality in hospitalized patients: A retrospective observational study.
PMC7314008 366. Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens.
PMC7310678 367. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries.
PMC7323090 377. Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: Initial experience at a single center in Madrid, Spain.
{{tp|p=32572194|t=2020. Myocardial injury in patients with COVID-19.|pdf=|usr=}} {{tp|p=32591754|t=2020. New insights into the neurological effects of COVID-19.|pdf=|usr=}} {{tp|p=32587102|t=2020. COVID-19-associated ophthalmoparesis and hypothalamic involvement.|pdf=|usr=}} {{tp|p=32592104|t=2020. COVID-19 and neurologic manifestations: a still missing link and a call for neurologists.|pdf=|usr=}} {{tp|p=32588367|t=2020. A prospective clinical study of detailed neurological manifestations in patients with COVID-19.|pdf=|usr=}} {{tp|p=32583169|t=2020. COVID-19-related strokes in adults below 55 years of age: a case series.|pdf=|usr=}} {{tp|p=32564270|t=2020. Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis.|pdf=|usr=}} {{tp|p=32570240|t=2020. Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy.|pdf=|usr=}} {{tp|p=32583042|t=2020. Kann SARS-CoV-2 das Auge infizieren? - Ein Uberblick uber den Rezeptorstatus in okularem Gewebe.|pdf=|usr=}} {{tp|p=32572552|t=2020. Welche Bedeutung hat die Bindehaut als moglicher Ubertragungsweg fur eine SARS-CoV-2-Infektion?|pdf=|usr=}} {{tp|p=32556553|t=2020. Erste Ergebnisse zu Untersuchungen der menschlichen Hornhaut auf SARS-CoV2-RNA.|pdf=|usr=}} {{tp|p=32585259|t=2020. Ocular symptoms among non-hospitalized patients who underwent COVID-19 testing.|pdf=|usr=}} {{tp|p=32539587|t=2020. Olfactory and Oral Manifestations of COVID-19: Sex-Related Symptoms-A Potential Pathway to Early Diagnosis.|pdf=|usr=}} {{tp|p=32539586|t=2020. Olfactory and Gustatory Dysfunction as an Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study.|pdf=|usr=}} {{tp|p=32549531|t=2020. The thromboembolism in COVID-19: the unsolved problem.|pdf=|usr=}} {{tp|p=32575004|t=2020. May Parkinson's disease be a protective factor against CNS involvement by SARS-CoV2?|pdf=|usr=}} {{tp|p=32575786|t=2020. Coronavirus Disease 2019 (COVID-19): A Short Review on Hematological Manifestations.|pdf=|usr=}} {{tp|p=32570959|t=2020. COVID-19 in Pregnant Women and Neonates: A Systematic Review of the Literature with Quality Assessment of the Studies.|pdf=|usr=}} {{tp|p=32564495|t=2020. SARS-CoV-2 infection in two pediatric patients with immune cytopenias: A single institution experience during the pandemic.|pdf=|usr=}} {{tp|p=32539221|t=2020. COVID-19 in a child with severe aplastic anemia.|pdf=|usr=}} {{tp|p=32542549|t=2020. Kawasaki Disease Features and Myocarditis in a Patient with COVID-19.|pdf=|usr=}} {{tp|p=32558360|t=2020. Asthma and COVID-19 in children - a systematic review and call for data.|pdf=|usr=}} {{tp|p=32558285|t=2020. COVID-19 cardiac involvement in a 38-day old infant.|pdf=|usr=}} {{tp|p=32543756|t=2020. Immune-related factors associated with pneumonia in 127 children with coronavirus disease 2019 in Wuhan.|pdf=|usr=}} {{tp|p=32559354|t=2020. A case of an Infant with SARS-CoV-2 hepatitis early after liver transplantation.|pdf=|usr=}} {{tp|p=32542914|t=2020. Varying presentations of COVID-19 in young heart transplant recipients: A case series.|pdf=|usr=}} {{tp|p=32544155|t=2020. Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series.|pdf=|usr=}} {{tp|p=32589691|t=2020. Analysis of clinical features and early warning signs in patients with severe COVID-19: A retrospective cohort study.|pdf=|usr=}} {{tp|p=32584868|t=2020. Sociodemographic, clinical and laboratory factors on admission associated with COVID-19 mortality in hospitalized patients: A retrospective observational study.|pdf=|usr=}} {{tp|p=32579597|t=2020. Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens.|pdf=|usr=}} {{tp|p=32574165|t=2020. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries.|pdf=|usr=}} {{tp|p=32555674|t=2020. Clinical characteristics of Coronavirus Disease 2019 patients in Beijing, China.|pdf=|usr=}} {{tp|p=32569293|t=2020. Biological sex impacts COVID-19 outcomes.|pdf=|usr=}} {{tp|p=32583378|t=2020. DGP-Empfehlungen zur pneumologischen Rehabilitation bei COVID-19.|pdf=|usr=}} {{tp|p=32576710|t=2020. Besides population age structure, health and other demographic factors can contribute to understanding the COVID-19 burden.|pdf=|usr=}} {{tp|p=32539139|t=2020. COVID-19, vision, and fitness to drive.|pdf=|usr=}} {{tp|p=32544034|t=2020. Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study.|pdf=|usr=}} {{tp|p=32571410|t=2020. Predictive factors of severe coronavirus disease 2019 in previously healthy young adults: a single-center, retrospective study.|pdf=|usr=}} {{tp|p=32559801|t=2020. Covid19 e gravidez: Uma visao geral.|pdf=|usr=}} {{tp|p=32542883|t=2020. COVID-19 and maternal pre-eclampsia; a synopsis.|pdf=|usr=}} {{tp|p=32562561|t=2020. Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: Initial experience at a single center in Madrid, Spain.|pdf=|usr=}}
378. Benign course of SARS-CoV-2 infection in a series of pediatric oncology patients.
387. Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)?
{{tp|p=32573939|t=2020. Benign course of SARS-CoV-2 infection in a series of pediatric oncology patients.|pdf=|usr=}} {{tp|p=32573924|t=2020. COVID-19 in pediatric hematopoietic stem cell transplantation: The experience of Spanish Group of Transplant (GETMON/GETH).|pdf=|usr=}} {{tp|p=32568457|t=2020. Statement on the prevention and treatment of COVID-19 in patients with pediatric cancer in Japan.|pdf=|usr=}} {{tp|p=32541844|t=2020. International comparison of guidelines for managing neonates at the early phase of the SARS-CoV-2 pandemic.|pdf=|usr=}} {{tp|p=32564046|t=2020. Coronavirus SARS-Cov-2 and arterial hypertension - facts and myths.|pdf=|usr=}} {{tp|p=32573311|t=2020. COVID-19 and comorbidities: A systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32554446|t=2020. Ophthalmological manifestations of COVID-19 and its transmissibility via ocular route.|pdf=|usr=}} {{tp|p=32571951|t=2020. Oligodendrocytes that survive acute coronavirus infection induce prolonged inflammatory responses in the CNS.|pdf=|usr=}} {{tp|p=32542238|t=2020. Acute smell and taste loss in outpatients: all infected with SARS-CoV-2?|pdf=|usr=}} {{tp|p=32557449|t=2020. Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)?|pdf=|usr=}} {{tp|p=32552412|t=2020. Cardiac Rehabilitation During COVID-19 Pandemic: Highlighting the Value of Home-Based Programs.|pdf=|usr=}} {{tp|p=32580993|t=2020. Asymptomatic SARS-CoV-2 infection: the tip or the iceberg?|pdf=|usr=}} {{tp|p=32575136|t=2020. Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection: Time to Rethink.|pdf=|usr=}} {{tp|p=32563062|t=2020. Increased rates of hand ischemia following arterial cannulation in patients with severe COVID19-related pneumonia.|pdf=|usr=}} {{tp|p=32583620|t=2020. COVID-19 in Recent Heart Transplant Recipients: Clinicopathologic Features and Early Outcomes.|pdf=|usr=}} {{tp|p=32578289|t=2020. COVID-19 infection in solid organ transplant recipients: a single center experience with patients immediately after transplantation.|pdf=|usr=}} {{tp|p=32573895|t=2020. SARS-CoV-2 infection in kidney transplant recipients: experience of the italian marche region.|pdf=|usr=}} {{tp|p=32573882|t=2020. COVID-19 Pneumonia in Kidney Transplant Recipients: Focus on Immunosuppression Management.|pdf=|usr=}} {{tp|p=32584760|t=2020. [Acral ischaemia with multiple microthromboses and imminent gangrene in a 73-year-old woman with COVID-19].|pdf=|usr=}} {{tp|p=32573042|t=2020. Increased rate of ruptured ectopic pregnancy in the COVID-19 pandemic: an analysis from the North of Italy.|pdf=|usr=}} {{tp|p=32588791|t=2020. Patterns of liver injury in COVID-19 - a German case series.|pdf=|usr=}}
